Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2012
10/24/2012CN101955905B Bacterial strain for producing Escherichia coli K88ac-K99-ST1-LTB quadrivalent gene engineering inactivated vaccines and inactivated vaccine production method
10/24/2012CN101889593B Functional incense and preparation method and application thereof
10/24/2012CN101880302B Polyhydroxylated sterol derivative as well as preparation and application thereof
10/24/2012CN101766690B Multipurpose utilization method for improving the value of schisandra chinensis medicinal material
10/24/2012CN101744946B Chinese medicinal composition and detection method for Chinese medicinal composition preparation
10/24/2012CN101711796B Application of scullcapflavone in preparing medicament for treating enterovirus infection
10/24/2012CN101607954B Danshensu derivative, preparation method thereof, and application thereof in pharmacy
10/24/2012CN101549154B Compositions comprising neisseria meningitidis antigens from serogroups B and C as well as a further antigen
10/24/2012CN101531578B Method for preparing axial chirality diaromatic compound with optical activity
10/24/2012CN101374844B Pyrrolopyridazinone compound
10/24/2012CN101321861B Method for generating dendritic cells employing decreased temperature
10/24/2012CN101180076B Use of an influenza virus an oil-in-water emulsion adjuvant to induce CD4 T-cell and/or improved B-memory cell response
10/24/2012CN101065131B Antimicrobial agents
10/23/2012US8293895 Carbapenem derivatives
10/23/2012US8293745 Use of imatinib to treat liver disorders and viral infections
10/23/2012US8293703 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/23/2012US8293283 Methods for treating oral cavity infections with chlorine dioxide
10/23/2012US8293273 Controlled release and taste masking oral pharmaceutical composition
10/23/2012US8293268 Local administration of gallium compositions to treat pain
10/23/2012CA2679626C Fluoroquinolones for treating, reducing, ameliorating, or preventing infections caused by antibacterial-drug resistant bacteria
10/23/2012CA2555279C Azepinoindole derivatives as pharmaceutical agents
10/23/2012CA2469599C Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof
10/23/2012CA2460749C Glycoconjugate vaccines for use in immune-compromised populations
10/23/2012CA2384978C Udp-n-acetylglucosamine: galactose-.beta.1,3-n-acetylgalactosamine-.alpha.-r/(glcnac to galnac) .beta.1,6-n-acetylglucosaminyltransferase, c2gnt3
10/23/2012CA2366216C Polycationic carbohydrates as immunostimulants in vaccines
10/18/2012WO2012142523A2 1'-substituted pyrimidine n-nucleoside analogs for antiviral treatment
10/18/2012WO2012142367A2 Compositions and methods for treatment of pulmonary diseases and conditions
10/18/2012WO2012142080A1 Thioamide, amidoxime and amidrazone derivatives as hiv attachment inhibitors
10/18/2012WO2012141989A2 Immunogens
10/18/2012WO2012141773A1 Methods and compositions for reducing shiga toxin induced toxicity in mammals
10/18/2012WO2012141704A1 Compounds for the treatment of hepatitis c
10/18/2012WO2012141674A2 Compositions and methods relating to argininosuccinate synthetase
10/18/2012WO2012141540A2 Novel isolated lactobacillus fermentum strain having viral infection inhibitory activity
10/18/2012WO2012141338A1 6,7 - dihydroimidazo [2, 1 - b] [1, 3] oxazine bactericides
10/18/2012WO2012140620A1 Compositions for preventing and/or treating an infection by an hiv-1 virus
10/18/2012WO2012140504A1 Therapeutic compounds
10/18/2012WO2012140365A1 Use of calixarenes associated with an antibiotic in the treatment of bacterial infections
10/18/2012WO2012140272A1 Treatment of microbial infections
10/18/2012WO2012140082A1 Treatment of hepatitis c virus infection with alisporivir
10/18/2012WO2012139930A1 Pyrazolyl-pyrimidine derivatives as kinase inhibitors
10/18/2012WO2012139918A1 Methods for treating bacterial infection
10/18/2012WO2012139521A1 Traditional chinese medicinal composition for preventing and treating influenza a and preparation method therefor and use thereof
10/18/2012WO2012139519A1 Cyclic peptide and medical use thereof
10/18/2012WO2012139485A1 Oral solid preparation of compound antituberculosis drug and preparation method thereof
10/18/2012WO2012139424A1 Crystalline forms of tebipenem, preparation methods and uses thereof in the preparation of medicines
10/18/2012WO2012139281A1 Adjuvant based on hiv tat and uses thereof
10/18/2012WO2012139225A1 Fusion proteins and combination vaccines comprising haemophilus influenzae protein e and pilin a
10/18/2012WO2012139179A1 Peptides with antimicrobial activity, drug compositions for the prophylaxis and treatment of animals, compositions for the prophylaxis and treatment of plants, uses of said peptides, and uses of paenibacillus elgii ourofinensis extract
10/18/2012WO2012095388A3 Compounds for treatment of feline leukemia in felidae
10/18/2012WO2012088577A3 Recombinant mycobacterium sp. protein, immunodiagnostic test and tuberculosis vaccine
10/18/2012WO2012073214A4 Heptose derivatives for use in the treatment of bacterial infections
10/18/2012US20120266262 Methods and compositions relating to zpa polypeptides
10/18/2012US20120264966 Sulfur-containing phospholipid derivatives
10/18/2012US20120264820 Synthetic Flavonoids and Pharmaceutical Compositions and Therapeutic Methods of Treatment of HIV infection and other pathologies
10/18/2012US20120264818 Topical Compositions with Cannabis Extracts
10/18/2012US20120264814 Isolation, Cloning, Sequencing and Functional analysis of ss-casein promoter along with the regions of exon1, intron1 and exon2 using mammary gland derived cell line of Buffalo (Bubulus bubalis)
10/18/2012US20120264802 Photosensitizers for targeted photodynamic therapy
10/18/2012US20120264798 Prodrugs of inhibitors of plasma kallikrein
10/18/2012US20120264793 Pharmaceutical Use of 2',2-Bis-Thiazole Non-Nucleoside Compounds as Hepatitis C Virus Inhibitor
10/18/2012US20120264780 Solid compositions
10/18/2012US20120264755 Pyridinyl derivatives as inhibitors of enzyme nicotinamide phosphoribosyltransferase
10/18/2012US20120264747 Triazolopyridine jak inhibitor compounds and methods
10/18/2012US20120264740 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
10/18/2012US20120264737 Heterocyclic Modulators of Lipid Synthesis
10/18/2012US20120264729 Co-crystals and salts of ccr3-inhibitors
10/18/2012US20120264727 Novel cephalosporin derivatives and pharmaceutical compositions thereof
10/18/2012US20120264726 Methods of sensitizing drug resistant microorganisms using methylsulfonylmethane (msm)
10/18/2012US20120264724 Antimicrobial agents based on hemin derivatives
10/18/2012US20120264717 Compounds, Compositions and Methods Comprising Oxadiazole Derivatives
10/18/2012US20120264716 Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264715 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264711 Antiviral compounds
10/18/2012US20120264710 Systems and Methods for Detecting hENT1 Expression in Hematological Disorders
10/18/2012US20120264709 Nucleotide and oligonucleotide prodrugs
10/18/2012US20120264707 Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis b
10/18/2012US20120264705 Antimicrobial compositions comprising 15-hetre and methods of use thereof
10/18/2012US20120264704 Substituted dihydropyrazolones and use thereof as hif-prolyl-4 -hydroxylase inhibitors
10/18/2012US20120264689 Methods and compositions for skin regeneration
10/18/2012US20120264679 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection
10/18/2012US20120264678 Methods of using [3.2.0] heterocyclic compounds and analogs thereof for treating infectious diseases
10/18/2012US20120264676 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
10/18/2012US20120263790 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/18/2012US20120263782 Methods and compositions for treating hiv infection
10/18/2012US20120263780 Carbohydrate Entrapped Active Agent Delivery Composition and Articles Using the Same
10/18/2012US20120263765 Agents from cells
10/18/2012US20120263763 Regenerative materials
10/18/2012US20120263756 Vaccines containing canine parvovirus genetic variants
10/18/2012US20120263755 Methods and compositions for eliciting an immune response against hepatitis b virus
10/18/2012US20120263754 Methods for Enhancing Immunogen Specific Immune Responses by Vectored Vaccines
10/18/2012US20120263752 Herpes Simplex Virus Vaccines
10/18/2012US20120263750 Recombinant modified vaccinia ankara (mva) vaccinia virus containing restructured insertion sites
10/18/2012US20120263747 Albumin-Fused Anti-Angiogenesis Peptides
10/18/2012US20120263745 Antichlamydial agents
10/18/2012US20120263744 Compositions And Methods Involving Respiratory Syncytial Virus Subgroup B Strain 9320
10/18/2012US20120263743 Influenza hemagglutinin compositions and uses thereof
10/18/2012US20120263738 Multiplex dicer substrate rna interference molecules having joining sequences
10/18/2012US20120263736 Method for predicting and treating a sterile inflammation and discriminating between sterile and infective inflammation
10/18/2012US20120263734 Compositions And Methods For The Therapy And Diagnosis Of Cytomegalovirus Infections
10/18/2012US20120263726 Pharmaceutical composition and method of inhibiting of production or amplifying of elimination of P24 protein
10/18/2012US20120263725 Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV